Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-02-23 Sale |
2021-02-25 8:25 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
15,000 | $33.59 | $503,877 | 47,969 (Direct) |
View |
| 2021-02-23 Sale |
2021-02-25 8:23 pm |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO, CBO & Secretary |
29,642 | $33.59 | $995,562 | 94,611 (Direct) |
View |
| 2021-02-23 Sale |
2021-02-25 8:22 pm |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
31,000 | $33.6 | $1,041,642 | 54,234 (Direct) |
View |
| 2021-02-23 Sale |
2021-02-25 8:20 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
10,000 | $33.55 | $335,538 | 169,420 (Direct) |
View |
| 2021-01-04 Sale |
2021-01-06 5:33 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
10,000 | $18.19 | $181,904 | 179,420 (Direct) |
View |
| 2020-12-30 Sale |
2021-01-04 6:06 pm |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO, CBO & Secretary |
358 | $20.04 | $7,175 | 91,753 (Direct) |
View |
| 2020-11-02 Sale |
2020-11-04 5:03 pm |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
6,000 | $17.14 | $102,812 | 72,734 (Direct) |
View |
| 2020-10-30 Purchase |
2020-11-03 7:56 pm |
KalVista Pharmaceuticals Inc. | KALV | Cha Albert Director |
115,686 | $17.24 | $1,994,068 | 1,138,179 (Indirect) |
View |
| 2020-10-29 Sale |
2020-11-02 8:01 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
5,000 | $17.48 | $87,394 | 62,969 (Direct) |
View |
| 2020-10-20 Sale |
2020-10-22 5:36 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
13,986 | $17.82 | $249,167 | 67,969 (Direct) |
View |
| 2020-10-20 Sale |
2020-10-22 5:34 pm |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
16,907 | $17.92 | $303,019 | 78,734 (Direct) |
View |
| 2020-10-20 Sale |
2020-10-22 5:33 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
38,539 | $17.98 | $693,025 | 195,420 (Direct) |
View |
| 2020-10-16 Sale |
2020-10-20 2:14 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
914 | $17 | $15,539 | 81,955 (Direct) |
View |
| 2020-10-16 Sale |
2020-10-20 2:11 pm |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
993 | $17 | $16,881 | 95,641 (Direct) |
View |
| 2020-10-16 Sale |
2020-10-20 2:08 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
1,261 | $17.01 | $21,444 | 233,959 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-03-18 Option Award |
2021-03-19 7:49 pm |
N/A 2031-03-17 |
KalVista Pharmaceuticals Inc. | KALV | Stuart Nancy Director |
14,000 | $0 | 14,000 (Direct) |
View |
| 2021-02-23 Exercise |
2021-02-25 8:23 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO, CBO & Secretary |
29,642 | $6.74 | 94,611 (Direct) |
View |
| 2021-02-23 Exercise |
2021-02-25 8:23 pm |
N/A 2026-12-28 |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO, CBO & Secretary |
29,642 | $0 | 94,611 (Direct) |
View |
| 2021-02-07 Option Award |
2021-02-08 9:35 pm |
N/A 2029-05-15 |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
51,000 | $0 | 51,000 (Direct) |
View |
| 2021-02-07 Option Award |
2021-02-08 9:35 pm |
N/A 2030-06-16 |
KalVista Pharmaceuticals Inc. | KALV | Smith Michael David Senior VP, Development |
16,500 | $0 | 16,500 (Direct) |
View |
| 2021-02-07 Option Award |
2021-02-08 9:34 pm |
N/A 2029-05-15 |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO, CBO & Secretary |
90,000 | $0 | 122,500 (Direct) |
View |
| 2021-02-07 Option Award |
2021-02-08 9:33 pm |
N/A 2029-05-15 |
KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas Senior Vice President, Medical |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-02-07 Option Award |
2021-02-08 9:33 pm |
N/A 2029-05-15 |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
55,000 | $0 | 127,734 (Direct) |
View |
| 2021-02-07 Option Award |
2021-02-08 9:32 pm |
N/A 2029-05-15 |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
115,000 | $0 | 115,000 (Direct) |
View |
| 2020-10-29 Gift |
2021-01-06 5:33 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
6,000 | $0 | 179,420 (Direct) |
View |
| 2020-12-30 Exercise |
2021-01-04 6:06 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO, CBO & Secretary |
358 | $6.74 | 91,753 (Direct) |
View |
| 2020-12-30 Exercise |
2021-01-04 6:06 pm |
N/A 2026-12-28 |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO, CBO & Secretary |
358 | $0 | 91,753 (Direct) |
View |
| 2020-12-16 Option Award |
2020-12-18 6:13 pm |
N/A 2030-06-16 |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
80,000 | $0 | 80,000 (Direct) |
View |
| 2020-12-16 Option Award |
2020-12-18 6:08 pm |
N/A 2030-06-16 |
KalVista Pharmaceuticals Inc. | KALV | Smith Michael David Senior VP, Development |
25,000 | $0 | 25,000 (Direct) |
View |
| 2020-12-16 Option Award |
2020-12-18 6:05 pm |
N/A 2030-06-16 |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO, CBO & Secretary |
85,000 | $0 | 85,000 (Direct) |
View |
| 2020-12-16 Option Award |
2020-12-18 6:02 pm |
N/A 2030-06-16 |
KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas Senior Vice President, Medical |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-12-16 Option Award |
2020-12-18 6:01 pm |
N/A 2030-06-16 |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
65,000 | $0 | 65,000 (Direct) |
View |
| 2020-12-16 Option Award |
2020-12-18 5:58 pm |
N/A 2030-06-16 |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
140,000 | $0 | 140,000 (Direct) |
View |
| 2020-04-29 Gift |
2020-10-20 2:08 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
3,000 | $0 | 233,959 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-02 8:40 pm |
N/A 2030-09-30 |
KalVista Pharmaceuticals Inc. | KALV | Unkart Edward W Director |
7,000 | $0 | 7,000 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-02 8:39 pm |
N/A 2030-09-30 |
KalVista Pharmaceuticals Inc. | KALV | Edwards Martin Director |
7,000 | $0 | 7,000 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-02 8:38 pm |
N/A 2030-09-30 |
KalVista Pharmaceuticals Inc. | KALV | SOLAND DANIEL B Director |
7,000 | $0 | 7,000 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-02 8:37 pm |
N/A 2030-09-30 |
KalVista Pharmaceuticals Inc. | KALV | SOLAND DANIEL B Director |
7,000 | $0 | 7,000 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-02 8:36 pm |
N/A 2030-09-30 |
KalVista Pharmaceuticals Inc. | KALV | Pereira Brian JG Director |
7,000 | $0 | 7,000 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-02 8:35 pm |
N/A 2030-09-30 |
KalVista Pharmaceuticals Inc. | KALV | ORONSKY ARNOLD L Director |
7,000 | $0 | 7,000 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-02 8:32 pm |
N/A 2030-09-30 |
KalVista Pharmaceuticals Inc. | KALV | Cha Albert Director |
7,000 | $0 | 7,000 (Direct) |
View |